Loading...
XNYS
RELX
Market cap59bUSD
Jul 28, Last price  
37.76USD
1D
5.92%
1Q
5.47%
Jan 2017
110.13%
Name

Relx PLC

Chart & performance

D1W1MN
XNYS:RELX chart
P/E
24.04
P/S
5.18
EPS
1.18
Div yield, %
2.34%
Shrs. gr., 5y
-0.99%
Rev. gr., 5y
6.17%
Revenues
9.59b
+1.65%
2,385,261,0002,424,936,0002,821,686,0003,211,559,0003,203,095,0003,175,058,0006,116,000,0006,035,000,0005,773,000,0005,971,000,0006,895,000,0007,355,000,0007,492,000,0007,874,000,0007,110,000,0007,244,000,0008,553,000,0009,161,000,0009,434,000,0009,590,000,000
Net income
2.07b
+6.77%
298,905,000848,252,000172,411,000177,724,000261,346,000290,548,0001,069,000,0001,110,000,000955,000,0001,008,000,0001,161,000,0001,659,000,0001,422,000,0001,505,000,0001,224,000,0001,471,000,0001,634,000,0001,781,000,0001,934,000,0002,065,000,000
CFO
2.84b
+8.74%
585,000,000829,000,000-11,000,000-8,000,000-5,000,000-3,000,0001,407,000,0001,386,000,0001,377,000,0001,407,000,0001,682,000,0001,848,000,0001,985,000,0002,089,000,0001,596,000,0002,016,000,0002,401,000,0002,457,000,0002,608,000,0002,836,000,000
Dividend
Aug 07, 20260.27851 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in London, United Kingdom, and established in 1903, RELX PLC (which rebranded from Reed Elsevier PLC in July 2015) offers sophisticated information analytics and decision-support tools to professional and business clientele across North America, Europe, and other international markets. Its operations are organized into four distinct divisions. The Risk division specializes in delivering analytics and decision systems that blend public and industry-specific data with advanced technology and algorithms, enabling clients to evaluate and anticipate various risks. The Scientific, Technical & Medical segment furnishes essential information and analytical insights to institutions and professionals, facilitating scientific advancement and improvements in healthcare. Within the Legal segment, the company supplies legal, regulatory, and commercial information and analytics, empowering customers' decision-making processes and enhancing their productivity. Lastly, the Exhibitions segment manages events, integrating in-person experiences with data and digital technologies to assist clients in understanding markets, identifying products, and closing deals.
IPO date
Apr 21, 1948
Employees
33,200
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT